Survivorship Benefits of Proton Therapy
by OncoLink Editorial Team
June 17, 2015

7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Sarcoma Characteristics ID'd in TP53 Mutation Carriers

Aug 22, 2011

Rhabdomyosarcoma likely <5 years, osteosarcoma at any age, leiomyosarcoma >20 years

Cixutumumab Tolerated for Pediatric Refractory Solid Tumors

Dec 22, 2011

Recommended phase II pediatric dose is 9 mg/kg intravenously once per week

Receptor in Osteosarcoma May Provide Treatment Approach

Dec 1, 2015

Interleukin-11 receptor alpha is highly expressed in primary osteosarcoma and lung metastases